FFCP PHASE1:Hg19::chr7:121944689..121944705,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=389549 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=22788 | |||
|TSSclassifier=strong | |||
|UniProt=A0PJY2 | |||
|association_with_transcript=-124bp_to_NM_001024613,NM_001160264,uc003vkc.2,uc003vkd.2_5end | |||
|cluster_id=chr7:121944689..121944705,- | |||
|coexpression_cluster_id=C90 | |||
|description=CAGE_peak_2_at_FEZF1_5end | |||
|id=chr7:121944689..121944705,- | |||
|ontology_enrichment_celltype=CL:0002322!2.28e-34!5;CL:0002605!7.85e-10!3;CL:0002178!1.40e-09!3;CL:0000333!5.57e-07!41 | |||
|ontology_enrichment_celltype_v019=CL:0002322;9.68e-53;5!CL:0002321;1.75e-39;15!CL:0000333;1.84e-14;5!CL:0000148;1.54e-07;10 | |||
|ontology_enrichment_celltype_v019_2=CL:0002322,9.05e-53,5;CL:0000148,1.52e-07,10;CL:0000541,1.52e-07,10 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:171!8.71e-25!10;DOID:3095!5.63e-11!22;DOID:2994!5.63e-11!22;DOID:3119!9.44e-08!14;DOID:5409!1.44e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:171;8.64e-42;10!DOID:3095;4.12e-19;22!DOID:2994;4.12e-19;22!DOID:169;3.26e-12;6!DOID:3193;8.69e-10;2!DOID:962;8.69e-10;2!DOID:1192;6.14e-07;3 | |||
|ontology_enrichment_disease_v019_2=DOID:171,8.64e-42,10;DOID:3095,4.12e-19,22;DOID:2994,4.12e-19,22;DOID:169,3.26e-12,6;DOID:3193,8.69e-10,2;DOID:962,8.69e-10,2;DOID:1192,6.14e-07,3 | |||
|ontology_enrichment_uberon=UBERON:0002022!1.21e-07!1;UBERON:0002346!6.73e-07!90 | |||
|ontology_enrichment_uberon_v019=UBERON:0002346;4.06e-38;4!UBERON:0000923;4.06e-38;4!UBERON:0010316;4.06e-38;4!UBERON:0005291;4.06e-38;4!UBERON:0002050;1.16e-30;5!UBERON:0005423;1.16e-30;5!UBERON:0000013;1.84e-14;5!UBERON:0002410;1.84e-14;5!UBERON:0003714;8.69e-10;2!UBERON:0000922;1.63e-09;49!UBERON:0000010;1.90e-08;8 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000013,1.84e-14,5;UBERON:0002410,1.84e-14,5;UBERON:0003714,8.69e-10,2;UBERON:0000010,1.90e-08,8 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.286235987131057,0.547497700291537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.07355300420312,2.91565490307268,0.580969714347592,3.21349270547648,1.51392510525377,1.45990943630332,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122988438543114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167516265334349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.18714054040822,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.755798243562828,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.344743373241465,1.74962768029953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.144090417154106,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0607495566580247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1251909307065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.17782897650661,0,6.44983613825296,27.4221646931171,0.867550349813015,17.8766373751438,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.11045493231545,0,0,0,0.606965604236632,0,0,0,0,0,0,0.118193840883968,0,0,0,0,0,0,0,0.0714765441766563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.098150233615243,0,0,0,0,0,0,0,0,0.11294608203896,0,1.50962843566674,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0679914901909147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p2@FEZF1 | |||
}} |
Latest revision as of 23:18, 15 September 2015
Short description: | p2@FEZF1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_FEZF1_5end |
Coexpression cluster: | C90_neuroectodermal_peripheral_neuroepithelioma_neuroblastoma_carcinoid_parietal_putamen |
Association with transcript: | -124bp_to_NM_001024613, NM_001160264, uc003vkc.2, uc003vkd.2_5end |
EntrezGene: | FEZF1 |
HGNC: | 22788 |
UniProt: | A0PJY2 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
embryonic stem cell | 9.05e-53 | 5 |
melanocyte | 1.52e-07 | 10 |
melanoblast | 1.52e-07 | 10 |
Ontology term | p-value | n |
---|---|---|
sympathetic nervous system | 1.84e-14 | 5 |
autonomic nervous system | 1.84e-14 | 5 |
neural tissue | 8.69e-10 | 2 |
peripheral nervous system | 1.90e-08 | 8 |
Ontology term | p-value | n |
---|---|---|
neuroectodermal tumor | 8.64e-42 | 10 |
germ cell and embryonal cancer | 4.12e-19 | 22 |
germ cell cancer | 4.12e-19 | 22 |
neuroendocrine tumor | 3.26e-12 | 6 |
peripheral nerve sheath neoplasm | 8.69e-10 | 2 |
neurofibroma | 8.69e-10 | 2 |
peripheral nervous system neoplasm | 6.14e-07 | 3 |